Efficacy of Terminalia arjuna in essential hypertension: A randomized controlled study
EXPLORE · 2026-11 · 22 (6) · 103535
DOI: 10.1016/j.explore.2026.103535 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift EXPLORE, 2026-11. Verfasst von Asgar Nazir und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Moalajat (Medicine), National Institute of Unani Medicine Bangalore, 560091, India. Electronic address: drasgarnazir11@gmail.com. Hauptthemen laut MEDLINE: Terminalia, Plant Extracts, Essential Hypertension, Antihypertensive Agents. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Moalajat (Medicine), National Institute of Unani Medicine Bangalore, 560091, India. Electronic address: drasgarnazir11@gmail.com.
- Department of Moalajat (Medicine), National Institute of Unani Medicine Bangalore, 560091, India.
- Department of Ilaj Bit Tadabir (Regimenal Therapy), National Institute of Unani Medicine Bangalore, 560091, India.
Zitieren
APA
Nazir, A., Bhat, M. D. A., & Mir, U. Y. (2026). Efficacy of Terminalia arjuna in essential hypertension: A randomized controlled study. EXPLORE, 22(6), 103535. https://doi.org/10.1016/j.explore.2026.103535
Vancouver
Nazir A, Bhat MDA, Mir UY. Efficacy of Terminalia arjuna in essential hypertension: A randomized controlled study. EXPLORE. 2026;22(6):103535. doi:10.1016/j.explore.2026.103535
BibTeX
@article{Nazir2026,
author = {Nazir, Asgar and Bhat, Muzafar Din Ahmad and Mir, Uzair Yousf},
title = {Efficacy of Terminalia arjuna in essential hypertension: A randomized controlled study},
journal = {EXPLORE},
year = {2026},
volume = {22},
number = {6},
pages = {103535},
doi = {10.1016/j.explore.2026.103535}
}
EUVIMED